PL371583A1 - Sposób wytwarzania 7 alfa-metylosteroidów - Google Patents

Sposób wytwarzania 7 alfa-metylosteroidów

Info

Publication number
PL371583A1
PL371583A1 PL03371583A PL37158303A PL371583A1 PL 371583 A1 PL371583 A1 PL 371583A1 PL 03371583 A PL03371583 A PL 03371583A PL 37158303 A PL37158303 A PL 37158303A PL 371583 A1 PL371583 A1 PL 371583A1
Authority
PL
Poland
Prior art keywords
methylsteroids
7alpha
preparation
Prior art date
Application number
PL03371583A
Other languages
English (en)
Other versions
PL208163B1 (pl
Inventor
J. Stoelwinder
M. Ostendorf
Buggenum P.A.M. Van
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of PL371583A1 publication Critical patent/PL371583A1/pl
Publication of PL208163B1 publication Critical patent/PL208163B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0085Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
PL371583A 2002-01-21 2003-01-14 Sposób wytwarzania 7 α-metylosteroidów PL208163B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02075230 2002-01-21

Publications (2)

Publication Number Publication Date
PL371583A1 true PL371583A1 (pl) 2005-06-27
PL208163B1 PL208163B1 (pl) 2011-03-31

Family

ID=8185555

Family Applications (1)

Application Number Title Priority Date Filing Date
PL371583A PL208163B1 (pl) 2002-01-21 2003-01-14 Sposób wytwarzania 7 α-metylosteroidów

Country Status (28)

Country Link
US (2) US20050090476A1 (pl)
EP (1) EP1470151B1 (pl)
JP (1) JP5250174B2 (pl)
KR (1) KR100937179B1 (pl)
CN (1) CN100372864C (pl)
AR (1) AR038165A1 (pl)
AT (1) ATE453659T1 (pl)
AU (1) AU2003205604B8 (pl)
BR (1) BRPI0306736B8 (pl)
CA (1) CA2472379C (pl)
DE (1) DE60330749D1 (pl)
EC (1) ECSP045180A (pl)
EG (1) EG23417A (pl)
ES (1) ES2336439T3 (pl)
HR (1) HRP20040634B1 (pl)
IL (2) IL162770A0 (pl)
IS (1) IS2740B (pl)
MX (1) MXPA04007049A (pl)
NO (1) NO327095B1 (pl)
NZ (1) NZ533970A (pl)
PE (1) PE20030926A1 (pl)
PL (1) PL208163B1 (pl)
RO (1) RO122913B1 (pl)
RS (1) RS51490B (pl)
RU (1) RU2305105C2 (pl)
TW (1) TWI322813B (pl)
WO (1) WO2003059931A1 (pl)
ZA (1) ZA200405257B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10213371C1 (de) * 2002-03-21 2003-12-24 Schering Ag Verfahren zur Herstellung von 7alpha-Methylsteroiden
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
DE10352433B4 (de) 2003-11-10 2012-10-11 Nanotecmarin Gmbh Polypeptid eines Silicatein-ß aus Suberites domuncula, dafür kodierende Nukleinsäure, deren Verwendungen, diese Nukleinsäure umfassender Vektor und dieses Polypeptid exprimierende Wirtszelle
KR100716981B1 (ko) * 2004-09-30 2007-05-10 삼성전자주식회사 대중교통의 최적경로 검색방법 및 이를 이용한 휴대용 기기
JP5749261B2 (ja) * 2009-06-29 2015-07-15 メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー 3,3,5,5−テトラメチルシクロヘキサノンを調製する方法
CN111944001A (zh) * 2020-07-09 2020-11-17 浙江神洲药业有限公司 一种替勃龙的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3470216A (en) * 1966-11-29 1969-09-30 Du Pont Selected 17,17-difluoro unsaturated androstanes
FR2054527B1 (pl) * 1969-07-28 1973-06-08 Roussel Uclaf
US3798213A (en) * 1971-01-25 1974-03-19 Merck & Co Inc 7 alpha-methyl-20-spiroxane-3-ones and process
DE2558088C2 (de) * 1975-12-19 1985-05-30 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten
JPS56145239A (en) * 1980-04-11 1981-11-11 Sumitomo Chem Co Ltd Novel bicyclooctane derivative and its preparation
US4298559A (en) * 1980-07-23 1981-11-03 Dow Corning Corporation High yield silicon carbide from alkylated or arylated pre-ceramic polymers
US6548491B2 (en) * 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
ATE246703T1 (de) * 1999-04-06 2003-08-15 Akzo Nobel Nv Oral wirksame 7-alpha-alkyl androgene
TW548277B (en) * 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
AU778017B2 (en) * 1999-12-02 2004-11-11 N.V. Organon 14,15-beta-methylene substituted androgens
WO2001058919A2 (en) * 2000-02-11 2001-08-16 Sri International Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
AU8201601A (en) * 2000-07-28 2002-02-13 Akzo Nobel Nv 16alpha-methyl or ethyl substituted estrogens
US20040010138A1 (en) * 2002-03-21 2004-01-15 Schering Ag Process for the production of 7alpha-methyl steroids
US7304157B2 (en) * 2004-09-28 2007-12-04 Bristol-Myers Squibb Company Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Also Published As

Publication number Publication date
EP1470151A1 (en) 2004-10-27
IS7339A (is) 2004-06-28
ECSP045180A (es) 2004-08-27
RU2004125580A (ru) 2006-01-27
JP5250174B2 (ja) 2013-07-31
YU63004A (sh) 2006-08-17
US20100204497A1 (en) 2010-08-12
IL162770A (en) 2011-06-30
TWI322813B (en) 2010-04-01
EP1470151B1 (en) 2009-12-30
ES2336439T3 (es) 2010-04-13
IL162770A0 (en) 2005-11-20
MXPA04007049A (es) 2004-10-14
AR038165A1 (es) 2004-12-29
BRPI0306736B8 (pt) 2021-05-25
KR100937179B1 (ko) 2010-01-19
RS51490B (sr) 2011-04-30
HRP20040634A2 (en) 2004-10-31
AU2003205604B2 (en) 2009-11-26
AU2003205604A1 (en) 2003-07-30
HRP20040634B1 (hr) 2013-07-31
WO2003059931A1 (en) 2003-07-24
ZA200405257B (en) 2005-08-31
TW200302731A (en) 2003-08-16
US20050090476A1 (en) 2005-04-28
JP2005519899A (ja) 2005-07-07
CN100372864C (zh) 2008-03-05
CA2472379A1 (en) 2003-07-24
RU2305105C2 (ru) 2007-08-27
CA2472379C (en) 2010-05-25
ATE453659T1 (de) 2010-01-15
BR0306736A (pt) 2004-12-28
DE60330749D1 (de) 2010-02-11
EG23417A (en) 2005-06-28
CN1863814A (zh) 2006-11-15
BRPI0306736B1 (pt) 2017-11-07
PL208163B1 (pl) 2011-03-31
RO122913B1 (ro) 2010-04-30
AU2003205604B8 (en) 2009-12-24
NZ533970A (en) 2005-10-28
NO327095B1 (no) 2009-04-20
IS2740B (is) 2011-06-15
KR20040077727A (ko) 2004-09-06
NO20043455L (no) 2004-08-19
PE20030926A1 (es) 2003-10-29

Similar Documents

Publication Publication Date Title
IL173456A0 (en) Process for the preparation of 4-amino-3-quinolinecarbonitriles
TWI350831B (en) Process for the preparation of ring compounds
HUP0500851A3 (en) Process for the preparation of rosuvastatin
HRP20050328A2 (en) Process for the preparation of (s,s)-cis-2-benzhyd
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
AU2003260983A1 (en) Processes for the preparation of s-(-)-amlodipine
TWI347945B (en) Process for the preparation of thiazolopyrimidines
IL165137A0 (en) Process for the preparation of thioalkylamine derivatives
EG23973A (en) Process for the preparation of urea ganules
AU2002367890A1 (en) Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate
PL371583A1 (pl) Sposób wytwarzania 7 alfa-metylosteroidów
PL373627A1 (pl) Sposób wytwarzania melaminy
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
AU2003278420A8 (en) Process for the preparation of ganciclovir
IL164788A0 (en) Process for the preparation of 3-isochromanone
IL161897A0 (en) Process for the preparation of cephalexin
PL368905A1 (pl) Sposób otrzymywania beta-jonylidenoacetaldehydu
ZA200509495B (en) Process for the preparation of nicotinaldehydes
PL374911A1 (pl) Sposób wytwarzania zaleplonu
EP1386911A3 (de) Verfahren zur Herstellung von Acyloxybenzolsulfonaten
HUP0300255A3 (en) Process for the preparation of 2-phenyl-4-methyl-1-tosil-piperazine
GB2390088B (en) Combustion process for the preparation of LiCoVO4
GB2390526B (en) Process for the preparation of fish portions
SI1673365T1 (sl) Postopek za pripravo Z-flupentiksola.